Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
healthcare data - search results
If you're not happy with the results, please do another search
PHE say one dose of vaccine 33.5% effective against Indian variant
Public Health England have found that both Pfizer and AstraZeneca vaccines against the Indian variant would have an efficacy of 33.5% in one dose.
How can digital transformation improve health & care?
Dr Philip Scott, Chair, BCS Health & Care, explores how digital transformation can improve our health and care.
Why do we need gender inclusive institutions?
Assistant Professor Rachel Brulé, Global Development Policy at Boston University, says that COVID exposed existing inequalities and explains why gender inclusive institutions can help.
Ethnic minorities had largest increase in cardiac deaths during pandemic
According to a new analysis by researchers, ethnic minorities in the US experienced disproportionately high levels of cardiac deaths during the pandemic - in comparison to the rates in 2019.
Medical devices: Technology addressing medical wellbeing
Bernard Ross, CEO of Sky Medical Technology, looks at how wearable medical technology can address some of the most critical medical issues of the 21st Century.
Tobacco dependency: Treat it like any other illness
Sarah MacFadyen, Vice Chair of the Taskforce for Lung Health and Head of Policy and External Affairs at Asthma UK and the British Lung Foundation, says it’s time that tobacco dependency was treated just like any other illness.
Pfizer vaccine can be given to 12-15 year olds in US
On Wednesday (12 May), the CDC announced that the Pfizer vaccine could now be given to 12-15 year olds - effective immediately for 17 million adolescents.
Research reveals five reasons behind UK vaccine hesitancy
New data explores why some in the UK continue to experience vaccine hesitancy - with one man explaining that "it is human nature to have second thoughts".
One in five UK adults experienced depression during lockdown
According to new ONS data, one in five adults experienced some form of depression during lockdown - more than double the pre-pandemic rate.
Drinking tea & coffee reduces risk of death in type-2 diabetes by 63%
A new study has found that drinking 4 cups of green tea or 2 cups of coffee per day reduces the risk of death in type-2 diabetes by 63%.
Turning the national illness service into the national health service
Robin Stern, Chair at Future Perfect (Healthcare), discusses how patient journeys currently reflect a national 'illness' service, not a national health service.
Brazilian COVID mutation more likely to evade immunity
The city of Manaus was hit so overwhelmingly by the Brazilian COVID mutation, it was believed that 75% of the population had COVID - what new truths are scientists learning about this powerful variant?
What are the side effects of the Pfizer vaccine?
Here, we assess some of the most common side effects of the Pfizer and BioNTech COVID-19 vaccine.
Cybersecurity threats to the COVID-19 vaccine
Raymond Pompon, Director of F5 Labs, looks at the cybersecurity threats to the COVID-19 vaccine amid the rise in cyber attacks since the onset of the pandemic.
EU to create new contract with Pfizer for 1.8 billion doses
Yesterday (14 April) EU President Ursula von der Leyen announced that the Commission would create a third contract with Pfizer, for 1.8 billion doses between 2021 to 2023.
New UK study will mix Moderna and Novavax COVID doses
Researchers in the UK started a clinical trial on mixing vaccines in February - today (14 April) a new study will look into mixing Moderna and Novavax doses.
US stops Johnson & Johnson vaccine to investigate blood clot risk
US authorities paused the use of the Johnson & Johnson single dose vaccine as they look into six cases of blood clots that developed in women aged between 18 and 48.
After COVID, can we better manage and prevent the likely rise in elderly falls?
Barak Katz, VP and GM Essence SmartCare, discusses the future of fall prevention and establishing more proactive elderly care, post COVID-19.
Why does the U.S. need an STI National Strategic Plan?
Open Access Government discusses STI prevention in the U.S., and the benefits and priorities of the STI National Strategic Plan 2021-2025.
Healthy under-30s should take alternative vaccine to AstraZeneca
The UK's medical authorities cleared continued use of AstraZeneca, but say that 18-29 year olds should take an alternative vaccine to AstraZeneca if possible.
